The fetal antigen i has been demonstrated by indirect immunofluorescence on cord erythrocytes and placental trophoblast. A patient with disseminated choriocarcinoma developed high-titre anti-i cold agglutinins, and minor elevation of anti-i titres was seen in four out of six further patients with treated choriocarcinoma. In normal pregnant women, 6% showed similar increases in anti-i titres.
SUMMARY
The fetal antigen i has been demonstrated by indirect immunofluorescence on cord erythrocytes and placental trophoblast. A patient with disseminated choriocarcinoma developed high-titre anti-i cold agglutinins, and minor elevation of anti-i titres was seen in four out of six further patients with treated choriocarcinoma. In normal pregnant women, 6% showed similar increases in anti-i titres.
The i and I erythrocyte antigens have recently been described as ceramide hepta and deca saccharides (Hakamori, 1977) . The fetal i character of erythrocytes changes after birth, and by 18 months of age the red cells carry mainly I (Marsh, 1961) . Detection of i substance has been reported in saliva, milk, amniotic fluid, ovarian cyst fluid, and serum (Race and Sanger, 1975) . In the following report, i antigen is demonstrated in placental trophoblast, and the development of an anti-i cold agglutinin is reported in a case of disseminated choriocarcinoma.
Case history
A 40-year-old woman had experienced abnormal postpartum vaginal bleeding for two years. She had passed blood clots and tissue fragments for eight months and had lost 5 kg in weight.
She appeared pale, and the uterus was enlarged to the size of an 18-week pregnancy. The liver and spleen were slightly enlarged.
A PrognosticonR pregnancy test was positive on urine diluted 1/10, and uterine curettings showed choriocarcinoma. Uterine ultrasound showed no pelvic wall invasion, and liver/spleen scans showed hepatosplenomegaly but without visible filling defects. Biochemical screening showed elevated alkaline phosphatase and lactate dehydrogenase, however, and a chest x-ray revealed multiple metastases in both lungs.
HAEMATOLOGY AND SEROLOGY
The Hb was 5-5 g/dl, and the blood smear showed a hypochromic microcytic picture and many red Received for publication 19 December 1978 Table 2 shows that anti-i serum and its cord red blood cells (RBC) eluate both stained placenta and cord erythrocytes but not adult erythrocytes. When the eluate was adsorbed with cord RBCs, the placental staining was markedly reduced, whereas adsorption with adult erythrocytes had no such effect. The absence of significant fluorescence in the AB serum B. J. Boughton (Hakamori, 1977) , which may be precursors of ABH and Lewis substances (Feizi et al., 1971) . They are also present in various endodermal tissues and body fluids and are subject to alteration when malignancy occurs in these sites. Thus, endodermal tumours may show deficiency of ABH substances, or an increase in I/i antigens (Salmon, 1978) . In some malignant disorders, a derepressed embryonic protein appears (carcinoembryonic antigen), and this is similar though not identical with i substance (Cooper et al., 1974) .
Antibodies to i substance are uncommon, however, except in infectious mononucleosis where they are formed in 8-66% of cases (Jenkins et al., 1965; Rosenfield et al., 1965) . Anti-i has also been reported in cirrhosis (Rubin and Solomon, 1967) and in lymphomas (Marsh, 1961) . In these circumstances, it has been suggested that anti-i appears as a 'nonspecific effect of intense synthetic activity in the R/E system', but in none of these cases has a source of i antigenic stimulation been identified.
The identification of i substance in normal placental trophoblast was predictable, and a search for anti-i antibodies in normal pregnancy sera revealed normal levels in 34 cases and minor elevations in two (6 %). Only one previous report of anti-i in pregnancy could be traced (Bell et al., 1967) , 
but the above findings suggest that it is not such a rarity.
In the case of disseminated choriocarcinoma, however, anti-i was present in high titre, and, despite its clinical insignificance, it produced autoagglutination of patient's red cells at 22°C and caused minor blood grouping and crossmatching difficulties.
A preliminary survey of six further cases of choriocarcinoma showed increased anti-i activity against adult-i cells (4 cases) and Cynamolgus monkey cells (3 cases). A patient with ovarian dysgerminoma showed similar findings. In these cases, titres of antibody were in the range 1/16-1/32 and were therefore similar to the 6 % normal pregnancies discussed above. Since these choriocarcinoma patients had received therapy for their malignancy, this may have reduced anti-i titres to some degree.
The usefulness of this new tumour marker needs to be pursued further, and the significance of anti-i formation in pregnancy and choriocarcinomatosis remains to be determined.
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